Drugs / RKI983
last change Jul 2007 re-read 3 minutes ago

RKI983

Developed for
ocular hypertension · open-angle glaucoma
Investigated by
Novartis

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00515424 Jul 2007 → ? ocular hypertension, open-angle glaucoma Novartis Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RKI983 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00515424 ↗